Furthermore, we found that the expression of GRB7 protein displayed a positive correlation with circCDYL2 in HER2+ breast cancer patient tissues who treated with anti-HER2 therapy (Fig. S3F, R = 0.65, P < 0.001). This evidence concerns the gene GRB7 and breast carcinoma.